New Advances in ATTRv-CM and ATTRv-PN: A CME Podcast for Clinicians
A New Chapter in the ATTR Story: From Nihilism to Optimism is a thought-provoking, on‑demand CME activity released on June 30, 2025, with the podcast launched on July 8, 2025. Ideal for clinicians in cardiology, neurology and multidisciplinary teams, the program delves into early diagnosis, therapeutic strategies, and best practices for managing ATTRv-CM and ATTRv-PN based on the latest clinical […]
FarmFest 2025
Join us for the 4th annual FarmFest on Saturday, August 9th at Highland Homestead in Pawcatuck, CT! FarmFest 2025 is dedicating proceeds from this year’s music festival to the BU Chobanian & Avedisian School of Medicine Amyloidosis Center. Enjoy a day of community on the farm with all-day local music & vendors to support the […]
Vaishali Sanchorawala, MD reviews the clinical challenges and intricacies of care associated with the management of light chain amyloidosis at ASH24.
https://medicaldigest.org/scientific-contents/interview:unraveling-data-and-care-strategies-al-amyloidosis
66th Annual Meeting of American Society of Hematology
Dr Sanchorawala discusses new research presented at the 66th Annual Meeting of American Society of Hematology in San Diego, CA in December 2024. https://www.vjhemonc.com/event/amyloidosis-sessions-highlights-from-ash-2024/
New study underway in Boston for people with advanced stage of AL amyloidosis
Few treatment options exist for patients with this life-threatening rare disease. New research is trying to change that.
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
The HELIOS B trial, recently published in NEJM, has unveiled promising results for patients with ATTR amyloidosis with cardiomyopathy (ATTR-CM). Vutrisiran, a cutting-edge siRNA therapy, significantly reduced the risk of death and cardiac events compared to placebo. Over 36 months, Vutrisiran also showed improvements in walking distance and quality of life. These findings highlight a […]
ISA 2024 Report
Click here to view a synopsis of the BU Amyloidosis Center’s attendance at the International Symposium on Amyloidosis at the Mayo Clinic May 26-30, 2024.
Statement on Amyloidosis by Ann Peel for the U.S. Senate
Click here to see full statement.
2024 Webinar: ATTR Cardiac Amyloidosis
What’s new and exciting in ATTR cardiac amyloidosis in 2024 Dr. Fredrick Ruberg and Dr. Omar Siddiqi discuss the general overview of ATTR treatment with new developments over the past year (APOLLO-B, ATTRibute-CM), currently enrolled trials (HELIOS-B, CARDIOTTRansform), and future trials (DepleTTR-CM, MAGNITUDE). They will also cover current heart failure therapy updates (SGLT2i) and imaging […]
Amyloidosis Language Included in the Fiscal Year 2024 Senate Bill and Report
2024 Omnibus Amyloidosis Report Language